ArticleFrontiers in human neuroscience2025
Protocol for a randomized controlled trial: efficacy and mechanisms of dual-target anodal tDCS in post-stroke cognitive impairment.
Article in Frontiers in human neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Immediate excitatory effect of transcranial ultrasound intensity on the human primary motor cortex: a double-blind, sham-controlled and crossover study.Frontiers in human neuroscience · 2026Article
- Neuromodulation and rehabilitation of post-stroke cognitive impairment: challenges and prospects.Frontiers in psychiatry · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Post-stroke cognitive impairment (PSCI) significantly hinders functional recovery and quality of life in stroke survivors. Although transcranial direct current stimulation (tDCS) has emerged as a promising non-invasive neuromodulation technique to improve cognitive function, conventional single-target tDCS approaches often yield inconsistent outcomes across cognitive domains. Methods: This randomized controlled trial aims to investigate the efficacy and underlying neural mechanisms of dual-target anodal tDCS (a-tDCS) in individuals with PSCI. Sixty participants will be randomly assigned to either a dual-target stimulation group or a single-target stimulation group. Each group will receive 10 sessions of tDCS over two weeks. Cognitive performance will be assessed using the Montreal Cognitive Assessment (MoCA) as the primary outcome, while secondary outcomes include the digit span test, Trail Making Test, and modified Barthel Index. Functional near-infrared spectroscopy (fNIRS) will be used to assess cortical activation and functional connectivity before and after the intervention. Discussion: The findings are expected to provide evidence on the efficacy and underlying mechanisms of dual-target tDCS in PSCI rehabilitation, potentially offering a more effective neuromodulatory intervention strategy for cognitive recovery in stroke survivors. Clinical trial registration: http://www.chictr.org.cn, identifier ChiCTR2500096896.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.